#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroendocrine tumour Neuronal ceroid lipofuscinosis Congenital myopathy Microvillous inclusion disease Tuberous sclerosis complex Barth syndrome Chronic myelomonocytic leukaemia Haemophilia Fatty acid oxidation disorder Choroid melanoma PIK3CA related overgrowth spectrum Cardiac amyloidosis Noonan syndrome Polyneuropathy Bronchopulmonary aspergillosis More trials…

    Learn about Rare Diseases

    Malignant fibrous histiocytoma – Diagnostics Mucopolysaccharidosis – Diagnostics Optic glioma – Basic Information Hereditary ataxia – Treatment Mast cell activation syndrome – Treatment Mantle cell lymphoma stage IV – Basic Information Paroxysmal nocturnal haemoglobinuria Progressive multifocal leukoencephalopathy – Life with Disease Chronic granulomatous disease – Diagnostics Tuberous sclerosis complex – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Calcium Levofolinate Cinchocaine Hydrochloride Pilocarpine Hydrochloride Phleum Pratense (225) Azathioprine Quc398 F125/10 Tazemetostat Pomalidomide Vancomycin Eplerenone Imlifidase Gad20-209-Fsp-A2 Treprostinil Sodium Heparin HUMAN THROMBIN Sitagliptin Enomimeran Vedolizumab Fludarabine More therapies…

    Learn about Your Condition

    Chronic coronary syndrome Meniere's disease Corneal graft failure Myocardial infarction Juvenile psoriatic arthritis Pyoderma Clostridium difficile colitis Childhood asthma Tuberculosis Insulin resistance Pancreatic fistula Testis cancer Dry eye Hyperoxaluria Urethral stenosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Iceland

  • Study on the Effect of Adding Thoracic Radiotherapy to Durvalumab and Chemotherapy for Patients with Extensive Stage Small-Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Durvalumab
    Estonia Iceland The Netherlands Norway Sweden

  • Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Prednisone
    • Secukinumab
    Belgium Czechia Denmark Finland France Germany +9

  • Study on Reduced BCG Dwell-Time for Patients with High-Risk Urothelial Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Denmark Iceland Sweden

  • Study on Ticagrelor and Acetylsalicylic Acid for Patients with Acute Coronary Syndrome Undergoing Coronary Artery Bypass Grafting

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Ticagrelor
    Denmark Finland Iceland Norway Sweden

  • Study on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions

    Not recruiting

    3 1
    Investigated Drugs:
    • Pelacarsen
    Austria Belgium Bulgaria Czechia Denmark France +14
Previous Page
1 … 3 4 5

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Acetylcysteine Amide Cytarabine Pelacarsen Aficamten Lenalidomide Dexamethasone Prednisolone Sodium Succinate Methotrexate 1-{6-[(4M)-4-(5-Chloro-6-Methyl-1H -Indazol-4-Yl)-5-Methyl-3-(1-Methyl-1H -Indazol-5-Yl)-1H -Pyrazol-1-Yl]-2-Azaspiro[3.3]Heptan-2-Yl}Prop-2-En-1-One Hydrocortisone Human Albumin Solution Hydrocortisone Sodium Phosphate Triamcinolone Hexacetonide Prednisone Docetaxel Methylprednisolone Tafasitamab Blinatumomab Certolizumab Pegol Secukinumab Terbinafine Etoposide Rituximab Leflunomide Apixaban Terbinafine Hydrochloride Fludarabine Phosphate SAROGLITAZAR HEMIMAGNESIUM Imatinib Abatacept Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acute lymphocytic leukaemia Acute myeloid leukaemia Arteriosclerosis Atrial fibrillation Bladder transitional cell carcinoma Breast cancer Cerebral amyloid angiopathy Chronic kidney disease Coronary artery disease Dyslipidaemia Dyspepsia End stage renal disease Follicular lymphoma Hypertrophic cardiomyopathy Infertility Intensive care Non-small cell lung cancer Plasma cell myeloma Primary biliary cholangitis Rheumatoid arthritis Small cell lung cancer extensive stage Transitional cell carcinoma

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!